← Back to Search

Procedure

Shoulder Surgery for Shoulder Dislocation (ATRASI Trial)

N/A
Recruiting
Led By Ivan H Wong, MD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
2 or more documented incidences of anterior glenohumeral dislocation
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

ATRASI Trial Summary

This trial will compare the outcomes of two shoulder surgery options to see which is better.

Who is the study for?
This trial is for individuals who have experienced at least two documented shoulder dislocations. It's not suitable for those with multidirectional instability, pregnancy, paralysis of the shoulder, cancer, severe systemic illness, uncontrolled diabetes (Hgb A1C >7%), previous surgery on the affected shoulder or posterior instability.Check my eligibility
What is being tested?
The study compares two arthroscopic treatments for recurrent anterior shoulder instability: anatomic glenoid reconstruction with bone graft versus Bankart repair. The effectiveness will be measured using WOSI scores and rates of re-dislocation/subluxation among other factors in a randomized controlled setting.See study design
What are the potential side effects?
Potential side effects may include complications related to surgery such as infection or bleeding, issues from anesthesia, pain at the surgical site, limited range of motion during recovery period and possible recurrence of dislocation.

ATRASI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My shoulder has dislocated forward two or more times.

ATRASI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
WOSI Score
Secondary outcome measures
Recurrent Instability

ATRASI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Anatomic Glenoid ReconstructionExperimental Treatment1 Intervention
Arthroscopic distal tibia bone graft
Group II: Bankart repairActive Control1 Intervention
Arthroscopic bankart repair

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
257 Previous Clinical Trials
83,614 Total Patients Enrolled
2 Trials studying Shoulder Dislocation
88 Patients Enrolled for Shoulder Dislocation
Ivan H Wong, MDPrincipal InvestigatorNova Scotia Health Authority
2 Previous Clinical Trials
260 Total Patients Enrolled

Media Library

Anatomic Glenoid Reconstruction (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT02510625 — N/A
Shoulder Dislocation Research Study Groups: Bankart repair, Anatomic Glenoid Reconstruction
Shoulder Dislocation Clinical Trial 2023: Anatomic Glenoid Reconstruction Highlights & Side Effects. Trial Name: NCT02510625 — N/A
Anatomic Glenoid Reconstruction (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02510625 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a possibility for me to partake in this investigation?

"This medical study is targeting individuals between 15 and 60 years old that have shoulder dislocation. Applications are accepted from up to 200 people."

Answered by AI

Are there vacancies yet for participants in this research endeavor?

"According to clinicaltrials.gov, this research is currently accepting participants. The trial was opened on September 1st 2015 and its parameters were last revised on March 7th 2022."

Answered by AI

What is the current quota of participants for this trial?

"Affirmative. Clinicaltrials.gov data affirms that this study is presently recruiting, with inception having been on September 1st 2015 and the latest update occurring on March 7th 2022. 200 patients are being admitted from a single site."

Answered by AI

Is the current research enrolling elderly individuals?

"Per the requirements of this medical trial, individuals must be between 15 and 60 years old in order to qualify."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability
Ivan Wong 2015. "The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02510625.
~4 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top